Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/53378
Title: Potentially inappropriate Prescribing for Adults with Diabetes Mellitus: A Scoping Review
Contributor(s): Ayalew, Mohammed Biset  (author)orcid ; Dieberg, Gudrun  (author)orcid ; Quirk, Frances  (author); Spark, Joy M  (author)orcid 
Publication Date: 2021
Open Access: Yes
Handle Link: https://hdl.handle.net/1959.11/53378
Open Access Link: https://www.une.edu.au/research/hdr/postgraduate-conferenceOpen Access Link
Abstract: 

Inappropriate prescribing is a significant health care management concern and a potential threat to patient safety. People with diabetes mellitus (DM) are at high risk for potentially inappropriate prescribing (PIP) as they often experience multiple comorbidity and polypharmacy. Objective: The aim of this scoping review was to explore and map studies conducted on PIP among people with DM and identify gaps in the study of PIP among this group of people. Methods: PIP was the concept of interest for this scoping review. Studies that reported any type of PIP (contraindication, omission, dosing problem, drug-drug interaction (DDI), inappropriate selection, unnecessary drug therapy) were included. Studies conducted on people aged <18 years of age or with the diagnosis of gestational DM or prediabetes were excluded. No restrictions to language, study design, publication status, geographic area, or clinical setting were applied in selecting the studies. Articles were systematically searched from 11 databases. Results: Among the 190 studies included in this review, the majority (64.0%) were conducted in high income countries. Clinical practice guidelines were the most frequently used standard references for identifying PIP. None of the studies used an explicit tool specifically designed to identify PIP among people with DM. Nearly half (47.4%) of the studies reported contraindications. The most frequently reported PIP in high income countries was contraindication while in low- and middle-income countries prescribing omission was the most common. Software and websites were mostly used for identifying DDIs. The specific events and conditions that were considered as inappropriate were not consistent across the studies. Conclusion: Contraindications, prescribing omissions and dosing problems were the most commonly reported PIPs. Prescribers should carefully consider the individual prescribing recommendations of a medication. Future studies focusing on the development of explicit tools to identify PIP for people with DM are needed.

Publication Type: Conference Publication
Conference Details: Intersections of Knowledge 2021: UNE Postgraduate Conference 2021, Armidale, Australia, 23rd - 24th June, 2021
Source of Publication: UNE Postgraduate Conference 2021: "Intersections of Knowledge" Conference Proceedings, p. 41-41
Publisher: University of New England
Place of Publication: Armidale, Australia
Fields of Research (FoR) 2020: 321403 Clinical pharmacy and pharmacy practice
Socio-Economic Objective (SEO) 2020: 200105 Treatment of human diseases and conditions
HERDC Category Description: E3 Extract of Scholarly Conference Publication
Appears in Collections:Conference Publication
School of Rural Medicine
School of Science and Technology

Files in This Item:
2 files
File Description SizeFormat 
Show full item record

Page view(s)

1,250
checked on Aug 3, 2024

Download(s)

4
checked on Aug 3, 2024
Google Media

Google ScholarTM

Check


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.